ArticlePolymers2026
A Reaction-Diffusion Model for Capturing Mass Loss and Microstructure Evolution in Enzymatic Degradation of Poly(
Article in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The microstructure of semicrystalline bioresorbable polymers is central to their biomedical performance because the crystalline content influences both the mechanical stability and the degradation behaviour. Experimental studies have shown that crystallinity evolves concurrently with mass loss during enzymatic degradation. However, most existing models represent the material as a single homogeneous structure, preventing them from capturing this microstructural evolution or the state-selective mechanisms that drive it. We present a one-dimensional partial differential equation model for the enzymatic degradation of thin films, which treats the crystalline and amorphous states as distinct reactive components. Calibrated to poly(ε-caprolactone) (PCL) degraded by
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.